leadf
logo-loader

The Medical Cannabis and Wellness ETF PM says GW Pharma deal validates pharmaceutical cannabinoids

The Medical Cannabis and Wellness UCITS ETF (LON:CBDP) Portfolio Manager Nawan Butt offers his thoughts on the recent $7.2B acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals, and how this deal will affect the medical cannabis sector.

GW Pharmaceuticals makes up 14% of the Medical Cannabis and Wellness UCITS ETF's portfolio. The fund, that falls under the HANetf umbrella, recently celebrated its one year anniversary, has delivered a return of 39.47% over the past three months and 40.41% over the last 12 months.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

IQ Geo Group's new European Regional Manager explains strategy to expand...

IQ Geo's (LON:IQG) new European Regional Manager Richard Weiss joins Proactive London's Katie Pilbeam about his new role as European Regional Manager. Weiss is a geospatial industry veteran with 25 years’ experience and joins from 3-GIS where he was managing director for Europe, the Middle...

11 minutes ago

2 min read